WT1/EGR1-mediated Control of STIM1 Expression and Function in Cancer Cells

Overview

Journal Front Biosci (Landmark Ed)

Specialty Biology

Date 2011 May 31

PMID 21622185

Citations 16

Authors

Michael F Ritchie

Yandong Zhou

Jonathan Soboloff

Affiliations

Soon will be listed here.

Abstract

There have been numerous publications linking Ca(2+) signaling and cancer, however, a clear explanation for this link has remained elusive. We recently identified the oncogenes/tumor suppressors Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) as regulators of the expression of STIM1, an essential regulator of Ca(2+) entry in non-excitable cells. The current review focuses on the literature defining both differential Ca(2+) signaling and WT1/EGR1 expression patterns in 6 specific cancer subtypes: Acute Myeloid Leukemia, Wilms Tumor, breast cancer, ovarian cancer, glioblastoma and prostate cancer. For each tumor-type, we have assessed how specific changes in WT1 and EGR1 expression might contribute to aberrant Ca(2+) homeostasis as well as the therapeutic potential of these observations.

Citing Articles

Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy.

Nian Q, Lin Y, Zeng J, Zhang Y, Liu R Transl Oncol. 2024; 52():102237.

PMID: 39672002 PMC: 11700300. DOI: 10.1016/j.tranon.2024.102237.

Early growth response 1 as a podocyte injury marker in human glomerular diseases.

Okabe M, Koike K, Yamamoto I, Tsuboi N, Matsusaka T, Yokoo T Clin Kidney J. 2024; 17(1):sfad289.

PMID: 38186896 PMC: 10768762. DOI: 10.1093/ckj/sfad289.

Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca -dependent kinase and phosphatase activity in the mouse heart.

Collins H, Anderson J, Wende A, Chatham J Physiol Rep. 2022; 10(4):e15177.

PMID: 35179826 PMC: 8855923. DOI: 10.14814/phy2.15177.

Deletion of the Wilms' Tumor Suppressor Gene in the Cardiac Troponin-T Lineage Reveals Novel Functions of WT1 in Heart Development.

Diaz Del Moral S, Barrena S, Hernandez-Torres F, Aranega A, Villaescusa J, Gomez Doblas J Front Cell Dev Biol. 2021; 9:683861.

PMID: 34368133 PMC: 8339973. DOI: 10.3389/fcell.2021.683861.

Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34.

Naziris N, Pippa N, Sereti E, Chrysostomou V, Kedzierska M, Kajdanek J Int J Mol Sci. 2021; 22(12).

PMID: 34200955 PMC: 8230631. DOI: 10.3390/ijms22126271.

References

Yang S, Zhang J, Huang X . Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009; 15(2):124-34. DOI: 10.1016/j.ccr.2008.12.019. View

Silberstein G, Van Horn K, Strickland P, Roberts Jr C, DANIEL C . Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A. 1997; 94(15):8132-7. PMC: 21569. DOI: 10.1073/pnas.94.15.8132. View

Gong Y, Blok L, Perry J, Lindzey J, Tindall D . Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. Endocrinology. 1995; 136(5):2172-8. DOI: 10.1210/endo.136.5.7720667. View

Lomonosova E, Chinnadurai G . BH3-only proteins in apoptosis and beyond: an overview. Oncogene. 2009; 27 Suppl 1:S2-19. PMC: 2928556. DOI: 10.1038/onc.2009.39. View

Barbolina M, Adley B, Shea L, Stack M . Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer. 2008; 112(7):1632-41. DOI: 10.1002/cncr.23341. View

Stathopulos P, Zheng L, Li G, Plevin M, Ikura M . Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell. 2008; 135(1):110-22. DOI: 10.1016/j.cell.2008.08.006. View

Vanoverberghe K, Vanden Abeele F, Mariot P, Lepage G, Roudbaraki M, Bonnal J . Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ. 2003; 11(3):321-30. DOI: 10.1038/sj.cdd.4401375. View

Kreidberg J, Sariola H, LORING J, Maeda M, Pelletier J, Housman D . WT-1 is required for early kidney development. Cell. 1993; 74(4):679-91. DOI: 10.1016/0092-8674(93)90515-r. View

Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H . High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res. 2002; 8(5):1167-71. View

10.

Hamilton T, Borel F, Romaniuk P . Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1. Biochemistry. 1998; 37(7):2051-8. DOI: 10.1021/bi9717993. View

11.

Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S . Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000; 19(2):158-63. DOI: 10.1097/00004347-200004000-00010. View

12.

Boynton A, Whitfield J . Different calcium requirements for proliferation of conditionally and unconditionally tumorigenic mouse cells. Proc Natl Acad Sci U S A. 1976; 73(5):1651-4. PMC: 430357. DOI: 10.1073/pnas.73.5.1651. View

13.

Hohenstein P, Hastie N . The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006; 15 Spec No 2:R196-201. DOI: 10.1093/hmg/ddl196. View

14.

Bae S, Bae M, Ahn M, Son M, Lee Y, Bae M . Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 1999; 59(23):5989-94. View

15.

Soboloff J, Spassova M, Hewavitharana T, He L, Xu W, Johnstone L . STIM2 is an inhibitor of STIM1-mediated store-operated Ca2+ Entry. Curr Biol. 2006; 16(14):1465-70. DOI: 10.1016/j.cub.2006.05.051. View

16.

Greenlee R, Murray T, Thun M . Cancer statistics, 2001. CA Cancer J Clin. 2001; 51(1):15-36. DOI: 10.3322/canjclin.51.1.15. View

17.

Nakahara Y, Okamoto H, Mineta T, Tabuchi K . Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathol. 2005; 21(3):113-6. DOI: 10.1007/BF02482185. View

18.

Wang Q, Salman H, Danilenko M, Studzinski G . Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol. 2005; 204(3):964-74. DOI: 10.1002/jcp.20355. View

19.

Rong Y, Bultynck G, Aromolaran A, Zhong F, Parys J, De Smedt H . The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A. 2009; 106(34):14397-402. PMC: 2728114. DOI: 10.1073/pnas.0907555106. View

20.

Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T . Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998; 91(8):2969-76. View